Detection of markers of cardiovascular and renal risk in Cuba: Isle of Youth Study (ISYS)

Nephron - Clinical Practice

Volumn 117, Issue 4, 2011, Pages

  Herrera, R ^a   Almaguer, M ^a   Chipi, J ^d   Toirac, X ^d   Martinez O ^d   Castellanos, O ^e   Bacallao, J ^b   Licourt, R M ^f   Mulet, P ^f   Velasquez I ^f   Dieguez L ^f   Hernandez M C ^f   Caballero, W ^f   Urra, P ^c   Rodriguez Triana N ^d  

^a University of Medical Science   (Cuba)

^b Atherosclerosis Research and Reference Center   (Cuba)

^c CENTRO NACIONAL DE INFORMACIÓN DE CIENCIAS MÉDICAS   (Cuba)

^d Hospital Heroes del Baire   (Cuba)

^e Municipal Health Department   (Cuba)

^f Juan M Páez Incháustegui Polyclinic ^*  (Cuba)

Author keywords

Cardiovascular and cerebrovascular disease; Chronic kidney disease; Chronic vascular diseases; Classification tree model; Diabetes mellitus; Hypertension; Isle of Youth Study, Cuba; Renovascular damage markers

Indexed keywords

ALBUMIN; PROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CUBA; DIABETES MELLITUS; DISEASE MARKER; FEMALE; HEMATURIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEINURIA; QUESTIONNAIRE; RENOVASCULAR DISEASE; RISK FACTOR;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CUBA; FEMALE; HUMANS; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROTEINURIA; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 78149329535     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321505     Document Type: Article

References (41)

1. Dirks JH, de Zeeuw D, Agarwal SK, et al: Prevention of chronic kidney disease and vascular disease: toward global health. The Bellagio 2004 Declaration. Kidney Int 2005;68:S1-S6.
2. Dirks JH, Robison SW, Alderman M, et al: Meeting Report on the Bellagio Conference. Prevention of vascular diseases in emerging world: an approach to global health equity. Kidney Int 2006;70:1397-1402.
3. Herrera R, Almaguer M, et al: Atención de la insuficiencia renal crónica por el sistema de salud de Cuba. En Primera Conferencia de Consenso. Insuficiencia renal crónica, diálisis y trasplante renal. Publicación Científica 520. Washington, OPS, 1989, pp 131-137.
4. Coresh J, Astor B, Greene T, et al: Prevalence of chronic kidney disease and decreased kidney function in the adult US population. Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;1:1-12. (Pubitemid 36043346)
5. Centers for Disease Control and Prevention: Prevalence of chronic kidney disease and associated risk factors - United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007;56:161-165.
6. Hillege HL, Jaussen WMT, Bak AAA, et al: Microalbuminuria is common also in a nondiabetic, nonhypertensive population and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Int Med 2001;249:519-526. (Pubitemid 32823860)
7. Almaguer López M, Herrera Valdés R, Chipi Cabrera J, et al: Design and methodology of the Isle of Youth community-based epidemiological study of CKD, cardio-cerebral vascular disease, hypertension, and diabetes mellitus (ISYS). MEDICC Rev 2007;9:23-30.
8. Gansevoort RT, Verhave JC, Hillege HL, et al: The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int 2005;67(suppl 94):S28-S35.
9. Iseki K, Ikemiya Y, Iseki C, et al: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468-1474. (Pubitemid 36350012)
10. Ramírez SP, I-Hong Hsu S, McClellan W: Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program. Kidney Int 2003;63(suppl 83):S61-S65. (Pubitemid 36126845)
11. Li PK, Kwan BC, Leung CB, et al: Prevalence of silent kidney disease in Hong Kong: The Screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) Program. Kidney Int 2005;67(suppl 94):S36-S40.
12. Perico N, Plata R, Anabaya A, et al: Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in Bolivia. Kidney Int 2005;68(suppl 97):S87-S94.
13. Stidley CA, Shah VO, Scavini M, et al: The Zuni Kidney Project: a collaborative approach to an epidemic of kidney disease. J Am Soc Nephrol 2003;14(suppl 2):S139-S143. (Pubitemid 36750509)
14. Yamagata K, Yamagata Y, Kobayashi M, et al: A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 1996;45:281-288.
15. Nieuwhof C, Doorenbos C, Grave W, et al: A prospective study of the natural history of idiopathic non-proteinuric hematuria. Kidney Int 1996;49:222-225. (Pubitemid 26024238)
16. Remuzzi G, Weening JJ: Albuminuria as early test for vascular disease. Lancet 2005;365:556-557. (Pubitemid 40247897)
17. Pontremoli R, Leoncini G, Viazzi F, et al: Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension. J Am Soc Nephrol 2005;16(suppl 1):S39-S41. (Pubitemid 41725081)
18. Krimholtz MJ, Karalliedde J, Thomas S, et al: Albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease. J Am Soc Nephrol 2005;16(suppl 1):S42-S47. (Pubitemid 41725082)
19. Jong PE, Brenner BM: From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int 2004;66:2109-2118. (Pubitemid 41115274)
20. Bello AK, Nwankwo E, El Nahas AM: Prevention of chronic kidney disease: a global challenge. Kidney Int 2005;68(suppl 98):S11-S17.
21. Hillege HL, Fidler V, Diercks G, et al: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:9037-9038.
22. Rosas M, Attie F, Pastelin G, et al: Prevalence of proteinuria in Mexico: a conjunctive consolidation approach with other cardiovascular risk factors. The Mexican Health Survey 2000. Kidney Int 2005;68(suppl 97):S112-S119.
23. Iseki K: Screening for renal disease - what can be learned from the Okinawa experience. Nephrol Dial Transplant 2006;21:839-843.
24. Xue JL, Ma JZ, Louis TA, et al: Forecast of the number of patients with end-stage renal disease in the United States to the Year 2010. J Am Soc Nephrol 2001;12:2753-2758.
25. Locatelli F, Pozzoni P: Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure? Kidney Int 2006;69:2118-2120.
26. Hamer RA, El Nahas AM: The burden of chronic kidney disease. BMJ 2006;332:563-564. (Pubitemid 44365753)
27. United States Renal Data System 2007 Annual Data Report. Am J Kidney Dis 2008;51(suppl 1):S17-S32.
28. Haroun MK, Jaar BG, Hoffman SC, et al: Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003;14:2934-2941. (Pubitemid 37305656)
29. Hoy WE, Wang Z, Baker P, et al: Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int 2003;63(suppl 83):S66-S73. (Pubitemid 36126846)
30. McDonald SP, Russ GR: Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand. Kidney Int 2003;63(suppl 83):S123-S127. (Pubitemid 36126858)
31. Mani MK: Experience with a program for prevention of chronic renal failure in India. Kidney Int 2005;67(suppl 94):S75-S78.
32. Correa-Rotter R, Naicker S, Katz IJ, et al: Demographic and epidemiologic transition in the developing world: role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease. Kidney Int 2004;66(suppl 92):S32-S37.
33. Orth SR: Smoking - a renal risk factor. Nephron 2000;86:12-26.
34. Gambaro G, Verlato F, Budakovic A, et al: Renal impairment in renal cigarette smokers. J Am Soc Nephrol 1998;9:562-567.
35. Ordunez-Garcia P, Bernal Munoz JL, et al: Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens 2006;24:845-849. (Pubitemid 43670454)
36. Ríos Burrows N, Li Y, Williams DE: Racial and ethnic differences in trends of end-stage renal disease: United States, 1995-2005. Adv Chronic Kidney Dis 2008;15:147-152.
37. Segura J, Campo C, Ruilope LM: Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension. Kidney Int 2004;66(suppl 92):S45-S49. (Pubitemid 43361430)
38. Batlle D: Clinical and cellular markers of diabetic nephropathy. Kidney Int 2003;63:2319-2330.
39. Sarnak MJ, Levey AS: Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35(suppl 1):S117-S131. (Pubitemid 30183825)
40. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:296-305.
41. Ritz E, McClellan WM: Overview: increased cardiovascular risk in patients with minor renal dysfunction. An emerging issue with far-reaching consequences. J Am Soc Nephrol 2004;15:513-516. (Pubitemid 38294780)